BRAF and colorectal carcinoma: Ventana IHC assay using BRAF V600E (VE1) mouse monoclonal primary antibody was performed to screen for the BRAF V600E mutation in 779 patients, including 611 cases of CRC, 127 cases of PTC and 41 cases of malignant melanoma.